.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Cipla
Colorcon
Covington
Fish and Richardson
QuintilesIMS
Johnson and Johnson
Baxter
Deloitte
Fuji

Generated: June 22, 2017

DrugPatentWatch Database Preview

PRONESTYL Drug Profile

« Back to Dashboard

What is the patent landscape for Pronestyl, and what generic Pronestyl alternatives are available?

Pronestyl is a drug marketed by Apothecon and is included in three NDAs.

The generic ingredient in PRONESTYL is procainamide hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.

Summary for Tradename: PRONESTYL

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list99
Clinical Trials: see list1
Patent Applications: see list986
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRONESTYL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
PRONESTYL
procainamide hydrochloride
CAPSULE;ORAL007335-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Apothecon
PRONESTYL
procainamide hydrochloride
TABLET;ORAL017371-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apothecon
PRONESTYL
procainamide hydrochloride
INJECTABLE;INJECTION007335-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Apothecon
PRONESTYL
procainamide hydrochloride
TABLET;ORAL017371-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apothecon
PRONESTYL
procainamide hydrochloride
CAPSULE;ORAL007335-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Argus Health
Moodys
Fuji
Colorcon
Cerilliant
Harvard Business School
Cantor Fitzgerald
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot